1 false false false false false false false false false true false false false false false false No description of principal activity 2023-03-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 12453314 2023-03-01 2024-02-29 12453314 2024-02-29 12453314 2022-03-01 2023-02-28 12453314 2023-02-28 12453314 bus:Director1 2023-03-01 2024-02-29 12453314 core:WithinOneYear 2024-02-29 12453314 core:WithinOneYear 2023-02-28 12453314 bus:Micro-entities 2023-03-01 2024-02-29 12453314 bus:AuditExemptWithAccountantsReport 2023-03-01 2024-02-29 12453314 bus:FullAccounts 2023-03-01 2024-02-29 12453314 bus:SmallCompaniesRegimeForAccounts 2023-03-01 2024-02-29 12453314 bus:PrivateLimitedCompanyLtd 2023-03-01 2024-02-29
COMPANY REGISTRATION NUMBER: 12453314
ALLERGY MED LTD
FILLETED UNAUDITED FINANCIAL STATEMENTS
29 February 2024
ALLERGY MED LTD
STATEMENT OF FINANCIAL POSITION
29 February 2024
2024
2023
£
£
£
Current assets
48,206
15,454
Creditors: amounts falling due within one year
9,782
4,981
--------
--------
Net current assets
38,424
10,473
--------
--------
Total assets less current liabilities
38,424
10,473
Accruals and deferred income
600
600
--------
--------
37,824
9,873
--------
--------
Capital and reserves
37,824
9,873
--------
-------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
For the year ending 29 February 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 6 August 2024 , and are signed on behalf of the board by:
Dr P L B Chellappan Pillai
Director
Company registration number: 12453314
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 5 Ambrose Close, Orpington, BR6 9UD, UK.